{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:52:28Z","timestamp":1770987148012,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,9,23]],"date-time":"2008-09-23T00:00:00Z","timestamp":1222128000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1007\/s00213-008-1336-z","type":"journal-article","created":{"date-parts":[[2008,9,22]],"date-time":"2008-09-22T03:29:49Z","timestamp":1222054189000},"page":"579-587","source":"Crossref","is-referenced-by-count":17,"title":["Haloperidol and risperidone have specific effects on altered pain sensitivity in the ketamine model of schizophrenia"],"prefix":"10.1007","volume":"202","author":[{"given":"Axel","family":"Becker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gisela","family":"Grecksch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Zernig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Ladstaetter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Hiemke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,9,23]]},"reference":[{"key":"1336_CR1","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1176\/ps.2006.57.4.552","volume":"57","author":"American Psychiatric Association\u2019s Task Force on Research Ethics","year":"2006","unstructured":"American Psychiatric Association\u2019s Task Force on Research Ethics (2006) Ethical principles and practices for research involving human participants with mental illness. Psychiatr Serv 57:552\u2013557","journal-title":"Psychiatr Serv"},{"key":"1336_CR2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0166-4328(99)00163-1","volume":"109","author":"A Becker","year":"2000","unstructured":"Becker A, Grecksch G (2000) Social memory is impaired in neonatally ibotenic acid lesioned rats. Behav Brain Res 109:137\u2013140","journal-title":"Behav Brain Res"},{"key":"1336_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0091-3057(03)00139-4","volume":"76","author":"A Becker","year":"2003","unstructured":"Becker A, Grecksch G (2003) Haloperidol and clozapine affect social behaviour in rats postnatally lesioned in the ventral hippocampus. Pharmacol Biochem Behav 76:1\u20138","journal-title":"Pharmacol Biochem Behav"},{"key":"1336_CR4","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.pnpbp.2004.06.019","volume":"28","author":"A Becker","year":"2004","unstructured":"Becker A, Grecksch G (2004) Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity. Prog Neuropsychopharmacol Biol Psychiatry 28:1267\u20131277","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1336_CR5","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0278-5846(03)00080-0","volume":"27","author":"A Becker","year":"2003","unstructured":"Becker A, Peters B, Schroeder H, Mann T, Huether G, Grecksch G (2003) Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 27:687\u2013700","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1336_CR6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00213-006-0557-2","volume":"189","author":"A Becker","year":"2006","unstructured":"Becker A, Grecksch G, Schroeder H (2006) Pain sensitivity is altered in animals after subchronic ketamine treatment. Psychopharmacology (Berl) 189:237\u2013247","journal-title":"Psychopharmacology (Berl)"},{"issue":"Online Pub","key":"1336_CR7","first-page":"OL259","volume":"48","author":"HG Bernstein","year":"2002","unstructured":"Bernstein HG, Krell D, Emrich HM, Baumann B, Danos P, Diekmann S, Bogerts B (2002) Fewer beta-endorphin expressing arcuate nucleus neurons and reduced beta-endorphinergic innervation of paraventricular neurons in schizophrenics and patients with depression. Cell Mol Biol (Noisy-le-grand) 48(Online Pub):OL259\u2013OL265","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"1336_CR8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archsurg.1988.01400250059010","volume":"123","author":"LK Bickerstaff","year":"1988","unstructured":"Bickerstaff LK, Harris SC, Leggett RS, Cheah KC (1988) Pain insensitivity in schizophrenic patients. A surgical dilemma. Arch Surg 123:49\u201351","journal-title":"Arch Surg"},{"key":"1336_CR9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/00005053-200207000-00011","volume":"190","author":"R Blumensohn","year":"2002","unstructured":"Blumensohn R, Ringler D, Eli I (2002) Pain perception in patients with schizophrenia. J Nerv Ment Dis 190:481\u2013483","journal-title":"J Nerv Ment Dis"},{"key":"1336_CR10","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1067\/mcp.2002.127494","volume":"72","author":"J Brockm\u00f6ller","year":"2002","unstructured":"Brockm\u00f6ller J, Kirchheiner J, Schmider J, Walter S, Sachse C, M\u00fcller-Oerlinghausen B, Roots I (2002) The impact of the CYP2D6 polymorphism on haloperidol pharmacokinetics and on the outcome of haloperidol treatment. Clin Pharmacol Ther 72:438\u2013452","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl 6","key":"1336_CR11","first-page":"5","volume":"68","author":"PF Buckley","year":"2007","unstructured":"Buckley PF (2007) Receptor-binding profiles of antipsychotics: clinical strategies when switching between agents. J Clin Psychiatry 68(Suppl 6):5\u20139","journal-title":"J Clin Psychiatry"},{"key":"1336_CR12","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1080\/15287390590967522","volume":"68","author":"WH Chan","year":"2005","unstructured":"Chan WH, Sun WZ, Ueng TH (2005) Induction of rat hepatic cytochrome P-450 by ketamine and its toxicological implications. J Toxicol Environ Health A 68:1581\u20131597","journal-title":"J Toxicol Environ Health A"},{"key":"1336_CR13","first-page":"306","volume":"134","author":"R Charlier","year":"1961","unstructured":"Charlier R, Prost M, Binon F, Deltourg G (1961) Etude pharmacologique d\u2019un antitussif le fumarate acid, de phenethyl-1(propyne-2yl)-4-propionoxy-4-piperidine. Arch Int Pharmacodyn Ther 134:306\u2013327","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"1336_CR14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/1568007024606221","volume":"1","author":"RR Conley","year":"2002","unstructured":"Conley RR, Kelly DL (2002) Current status of antipsychotic treatment. Curr Drug Targets CNS Neurol Disord 1:123\u2013128","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"1336_CR15","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1749-6632.1982.tb39507.x","volume":"398","author":"GC Davis","year":"1982","unstructured":"Davis GC, Buchsbaum MS, Naber D, Pickar D, Post R, van Kammen D, Bunney WE Jr (1982) Altered pain perception and cerebrospinal endorphins in psychiatric illness. Ann N Y Acad Sci 398:366\u2013373","journal-title":"Ann N Y Acad Sci"},{"key":"1336_CR16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/schbul\/20.2.235","volume":"20","author":"RH Dworkin","year":"1994","unstructured":"Dworkin RH (1994) Pain insensitivity in schizophrenia: a neglected phenomenon and some implications. Schizophr Bull 20:235\u2013248","journal-title":"Schizophr Bull"},{"key":"1336_CR17","first-page":"265","volume-title":"Animal models in psychopharmacology","author":"BA Ellenbroek","year":"2007","unstructured":"Ellenbroek BA (2007) The ethological analysis of monkeys in a social setting as an animal model of schizophrenia. In: Olivier B, Mos J, Slangen JL (eds) Animal models in psychopharmacology. Birkh\u00e4user, Basel, pp 265\u2013284"},{"key":"1336_CR18","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0196-0644(82)80210-2","volume":"11","author":"DA Fishbain","year":"1982","unstructured":"Fishbain DA (1982) Pain insensitivity in psychosis. Ann Emerg Med 11:630\u2013632","journal-title":"Ann Emerg Med"},{"key":"1336_CR19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1526-4637.2004.04054.x","volume":"5","author":"DA Fishbain","year":"2004","unstructured":"Fishbain DA, Cutler RB, Lewis J, Cole B, Rosomoff RS, Rosomoff HL (2004) Do the second-generation \u201catypical neuroleptics\u201d have analgesic properties? A structured evidence-based review. Pain Med 5:359\u2013365","journal-title":"Pain Med"},{"key":"1336_CR20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.pain.2004.03.036","volume":"110","author":"JA Flores","year":"2004","unstructured":"Flores JA, El Banoua F, Galan-Rodriguez B, Fernandez-Espejo E (2004) Opiate anti-nociception is attenuated following lesion of large dopamine neurons of the periaqueductal grey: critical role for D1 (not D2) dopamine receptors. Pain 110:205\u2013214","journal-title":"Pain"},{"key":"1336_CR21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/archpsyc.64.1.76","volume":"64","author":"E Geuze","year":"2007","unstructured":"Geuze E, Westenberg HG, Jochims A, de Kloet CS, Bohus M, Vermetten E, Schmahl C (2007) Altered pain processing in veterans with posttraumatic stress disorder. Arch Gen Psychiatry 64:76\u201385","journal-title":"Arch Gen Psychiatry"},{"key":"1336_CR22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.psychres.2005.09.004","volume":"142","author":"T Jochum","year":"2006","unstructured":"Jochum T, Letzsch A, Greiner W, Wagner G, Sauer H, B\u00e4r KJ (2006) Influence of antipsychotic medication on pain perception in schizophrenia. Psychiatry Res 142:151\u2013156","journal-title":"Psychiatry Res"},{"key":"1336_CR23","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/sj.mp.4001093","volume":"7","author":"S Kapur","year":"2002","unstructured":"Kapur S, Seeman P (2002) NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia. Mol Psychiatry 7:837\u2013844","journal-title":"Mol Psychiatry"},{"key":"1336_CR24","doi-asserted-by":"crossref","first-page":"7788","DOI":"10.1523\/JNEUROSCI.21-19-07788.2001","volume":"21","author":"MA King","year":"2001","unstructured":"King MA, Bradshaw S, Chang AH, Pintar JE, Pasternak GW (2001) Potentiation of opioid analgesia in dopamine2 receptor knock-out mice: evidence for a tonically active anti-opioid system. J Neurosci 21:7788\u20137792","journal-title":"J Neurosci"},{"key":"1336_CR25","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1365\/s10337-007-0506-1","volume":"67","author":"KM Kirschbaum","year":"2008","unstructured":"Kirschbaum KM, Finger S, Vogel F, Burger R, Gerlach M, Riederer P, Hiemke C (2008) LC with column-switching and spectrophotometric detection for determination of risperidone and 9-hydroxyrisperidone in human serum. Chromatographia 67:321\u2013324","journal-title":"Chromatographia"},{"key":"1336_CR26","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2165\/00003088-199937060-00001","volume":"37","author":"S Kudo","year":"1999","unstructured":"Kudo S, Ishizaki T (1999) Pharmacokinetics of haloperidol: an update. Clin Pharmacokinet 37:435\u2013456","journal-title":"Clin Pharmacokinet"},{"key":"1336_CR27","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/00115550-200009000-00007","volume":"25","author":"A Kudoh","year":"2000","unstructured":"Kudoh A, Ishihara H, Matsuki A (2000) Current perception thresholds and postoperative pain in schizophrenic patients. Reg Anesth Pain Med 25:475\u2013479","journal-title":"Reg Anesth Pain Med"},{"key":"1336_CR28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0014-2999(94)00787-8","volume":"275","author":"H Kuribara","year":"1995","unstructured":"Kuribara H (1995) Modification of morphine sensitization by opioid and dopamine receptor antagonists: evaluation by studying ambulation in mice. Eur J Pharmacol 275:251\u2013258","journal-title":"Eur J Pharmacol"},{"key":"1336_CR29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1055\/s-2007-973836","volume":"40","author":"J Leon","year":"2007","unstructured":"Leon J, Susce MT, Pan RM, Wedlund PJ, Orrego ML, Diaz FJ (2007) A study of genetic (CYP2D6 and ABCB1) and environmental (drug inhibitors and inducers) variables that may influence plasma risperidone levels. Pharmacopsychiatry 40:93\u2013102","journal-title":"Pharmacopsychiatry"},{"key":"1336_CR30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1476-5381.1978.tb08641.x","volume":"64","author":"A Livingston","year":"1978","unstructured":"Livingston A, Waterman AE (1978) The development of tolerance to ketamine in rats and the significance of hepatic metabolism. Br J Pharmacol 64:63\u201369","journal-title":"Br J Pharmacol"},{"key":"1336_CR31","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000139276","volume":"50","author":"JM Loch","year":"1995","unstructured":"Loch JM, Potter J, Bachmann KA (1995) The influence of anesthetic agents on rat hepatic cytochromes P450 in vivo. Pharmacology 50:146\u2013153","journal-title":"Pharmacology"},{"key":"1336_CR32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.psychres.2005.04.009","volume":"149","author":"P Ludascher","year":"2007","unstructured":"Ludascher P, Bohus M, Lieb K, Philipsen A, Jochims A, Schmahl C (2007) Elevated pain thresholds correlate with dissociation and aversive arousal in patients with borderline personality disorder. Psychiatry Res 149:291\u2013296","journal-title":"Psychiatry Res"},{"key":"1336_CR33","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/0006-2952(77)90458-0","volume":"26","author":"MP Marietta","year":"1977","unstructured":"Marietta MP, Vore ME, Way WL, Trevor AJ (1977) Characterization of ketamine induction of hepatic microsomal drug metabolism. Biochem Pharmacol 26:2451\u20132453","journal-title":"Biochem Pharmacol"},{"key":"1336_CR34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/01.ftd.0000211812.27558.6e","volume":"28","author":"HP Maurer","year":"2006","unstructured":"Maurer HP, Sauer C, Theobald DS (2006) Toxicokinetics of drugs of abuse: current knowledge of the isoenzymes involved in the human metabolism of tetrahydrocannabinol, cocaine, heroin, morphine, and codeine. Ther Drug Monit 28:447\u2013453","journal-title":"Ther Drug Monit"},{"key":"1336_CR35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0014-2999(90)90007-S","volume":"187","author":"A Michael-Titus","year":"1990","unstructured":"Michael-Titus A, Bousselmame R, Costentin J (1990) Stimulation of dopamine D2 receptors induces an analgesia involving an opioidergic but non enkephalinergic link. Eur J Pharmacol 187:201\u2013207","journal-title":"Eur J Pharmacol"},{"key":"1336_CR36","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0091-3057(91)90560-O","volume":"40","author":"MJ Morgan","year":"1991","unstructured":"Morgan MJ, Franklin KB (1991) Dopamine receptor subtypes and formalin test analgesia. Pharmacol Biochem Behav 40:317\u2013322","journal-title":"Pharmacol Biochem Behav"},{"key":"1336_CR37","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archpsyc.1995.03950240016004","volume":"52","author":"JW Olney","year":"1995","unstructured":"Olney JW, Farber NB (1995) Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52:998\u20131007","journal-title":"Arch Gen Psychiatry"},{"key":"1336_CR38","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s002280050679","volume":"55","author":"L Pan","year":"1999","unstructured":"Pan L, Belpaire FM (1999) In vitro study on the involvement of CYP1A2, CYP2D6 and CYP3A4 in the metabolism of haloperidol and reduced haloperidol. Eur J Clin Pharmacol 55:599\u2013604","journal-title":"Eur J Clin Pharmacol"},{"key":"1336_CR39","first-page":"5","volume":"10","author":"E Richelson","year":"1999","unstructured":"Richelson E (1999) Receptor pharmacology of neuroleptics: relation to clinical effects. J Clin Psychiatry 60 Suppl 10:5\u201314","journal-title":"J Clin Psychiatry 60 Suppl"},{"key":"1336_CR40","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00213-003-1544-5","volume":"170","author":"H Russig","year":"2003","unstructured":"Russig H, Kovacevic A, Murphy CA, Feldon J (2003) Haloperidol and clozapine antagonise amphetamine-induced disruption of latent inhibition of conditioned taste aversion. Psychopharmacology (Berl) 170:263\u2013270","journal-title":"Psychopharmacology (Berl)"},{"key":"1336_CR41","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1037\/0735-7044.114.4.659","volume":"114","author":"NA Schmajuk","year":"2000","unstructured":"Schmajuk NA, Christiansen B, Cox L (2000) Haloperidol reinstates latent inhibition impaired by hippocampal lesions: data and theory. Behav Neurosci 114:659\u2013670","journal-title":"Behav Neurosci"},{"key":"1336_CR42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0304-3940(97)00345-5","volume":"228","author":"S Schreiber","year":"1997","unstructured":"Schreiber S, Backer MM, Weizman R, Pick CG (1997) Augmentation of opioid induced antinociception by the atypical antipsychotic drug risperidone in mice. Neurosci Lett 228:25\u201328","journal-title":"Neurosci Lett"},{"key":"1336_CR43","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/070674370204700106","volume":"47","author":"P Seeman","year":"2002","unstructured":"Seeman P (2002) Atypical antipsychotics: mechanism of action. Can J Psychiatry 47:27\u201338","journal-title":"Can J Psychiatry"},{"key":"1336_CR44","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1517\/14728222.10.4.515","volume":"10","author":"P Seeman","year":"2006","unstructured":"Seeman P (2006) Targeting the dopamine D2 receptor in schizophrenia. Expert Opin Ther Targets 10:515\u2013531","journal-title":"Expert Opin Ther Targets"},{"key":"1336_CR45","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0278-5846(02)00265-8","volume":"26","author":"A Serrano","year":"2002","unstructured":"Serrano A, Aguilar MA, Manzanedo C, Rodriguez-Arias M, Minarro J (2002) Effects of DA D1 and D2 antagonists on the sensitisation to the motor effects of morphine in mice. Prog Neuropsychopharmacol Biol Psychiatry 26:1263\u20131271","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1336_CR46","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0893-133X(00)00096-8","volume":"23","author":"E Shadach","year":"2000","unstructured":"Shadach E, Gaisler I, Schiller D, Weiner I (2000) The latent inhibition model dissociates between clozapine, haloperidol, and ritanserin. Neuropsychopharmacology 23:151\u2013161","journal-title":"Neuropsychopharmacology"},{"key":"1336_CR47","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0090-9556(24)15029-5","volume":"27","author":"JG Shin","year":"1999","unstructured":"Shin JG, Soukhova N, Flockhart DA (1999) Effect of antipsychotic drugs on human liver cytochrome P-450 (CYP) isoforms in vitro: preferential inhibition of CYP2D6. Drug Metab Dispos 27:1078\u20131084","journal-title":"Drug Metab Dispos"},{"key":"1336_CR48","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00131746-200603000-00004","volume":"12","author":"MK Singh","year":"2006","unstructured":"Singh MK, Giles LL, Nasrallah HA (2006) Pain insensitivity in schizophrenia: trait or state marker? J Psychiatr Pract 12:90\u2013102","journal-title":"J Psychiatr Pract"},{"key":"1336_CR49","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1742-7843.2007.00017.x","volume":"100","author":"E Spina","year":"2007","unstructured":"Spina E, de Leon J (2007) Metabolic drug interactions with newer antipsychotics: a comparative review. Basic Clin Pharmacol Toxicol 100:4\u201322","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1336_CR50","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/01.ftd.0000162868.84596.c3","volume":"27","author":"J Weide van der","year":"2005","unstructured":"van der Weide J, Baalen-Benedek EH, Kootstra-Ros JE (2005) Metabolic ratios of psychotropics as indication of cytochrome P450 2D6\/2C19 genotype. Ther Drug Monit 27:478\u2013483","journal-title":"Ther Drug Monit"},{"key":"1336_CR51","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/BF02244998","volume":"114","author":"EC Warburton","year":"1994","unstructured":"Warburton EC, Joseph MH, Feldon J, Weiner I, Gray JA (1994) Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: implications for a possible antipsychotic action of ondansetron. Psychopharmacology (Berl) 114:657\u2013664","journal-title":"Psychopharmacology (Berl)"},{"key":"1336_CR52","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0079-6123(08)64588-4","volume":"93","author":"VM Wiegant","year":"1992","unstructured":"Wiegant VM, Ronken E, Kovacs G, De Wied D (1992) Endorphins and schizophrenia. Prog Brain Res 93:433\u2013453","journal-title":"Prog Brain Res"},{"key":"1336_CR53","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00004714-199906000-00010","volume":"19","author":"JD Wines Jr","year":"1999","unstructured":"Wines JD Jr, Weiss RD (1999) Opioid withdrawal during risperidone treatment. J Clin Psychopharmacol 19:265\u2013267","journal-title":"J Clin Psychopharmacol"},{"key":"1336_CR54","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/0306-3623(92)90315-B","volume":"23","author":"MR Zarrindast","year":"1992","unstructured":"Zarrindast MR, Zarghi A (1992) Morphine stimulates locomotor activity by an indirect dopaminergic mechanism: possible D-1 and D-2 receptor involvement. Gen Pharmacol 23:1221\u20131225","journal-title":"Gen Pharmacol"},{"key":"1336_CR55","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/026988110201600312","volume":"16","author":"MR Zarrindast","year":"2002","unstructured":"Zarrindast MR, Dinkoub Z, Homayoun H, Bakhtiarian A, Khavandgar S (2002) Dopamine receptor mechanism(s) and morphine tolerance in mice. J Psychopharmacol 16:261\u2013266","journal-title":"J Psychopharmacol"},{"key":"1336_CR56","first-page":"1022","volume":"25","author":"CS Zhang","year":"2004","unstructured":"Zhang CS, Tan Z, Lu L, Wu SN, He Y, Gu NF, Feng GY, He L (2004) Polymorphism of prodynorphin promoter is associated with schizophrenia in Chinese population. Acta Pharmacol Sin 25:1022\u20131026","journal-title":"Acta Pharmacol Sin"},{"key":"1336_CR57","doi-asserted-by":"crossref","first-page":"14519","DOI":"10.1073\/pnas.0705740104","volume":"104","author":"ZQ Zhao","year":"2007","unstructured":"Zhao ZQ, Gao YJ, Sun YG, Zhao CS, Gereau RW, Chen ZF (2007) Central serotonergic neurons are differentially required for opioid analgesia but not for morphine tolerance or morphine reward. Proc Natl Acad Sci USA 104:14519\u201314524","journal-title":"Proc Natl Acad Sci USA"},{"key":"1336_CR58","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1038\/sj.npp.1300248","volume":"28","author":"L Zuckerman","year":"2003","unstructured":"Zuckerman L, Rehavi M, Nachman R, Weiner I (2003) Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology 28:1778\u20131789","journal-title":"Neuropsychopharmacology"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-008-1336-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-008-1336-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-008-1336-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T01:20:11Z","timestamp":1738372811000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-008-1336-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,23]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["1336"],"URL":"https:\/\/doi.org\/10.1007\/s00213-008-1336-z","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,23]]}}}